Fundz

Curevo reported raising $42.4 Million in an initial SEC Form D filing, from an offering of $84.8 Million

RECENTLY ACQUIREDMar 18, 2025

Amount Raised

$42.4 Million

$42.4 Million sold, per SEC Form D (first sale Mar 6, 2025)

Round Type

Venture

BothellBiotechnologyHealthcareMobileSportsPlatforms

Who to call at Curevo, and when

A new round usually means Curevo is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Curevo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Curevo, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Curevo

Location

Bothell, Washington, United States

About

Curevo is a clinical-stage biotechnology company dedicated to developing vaccines with improved tolerability and accessibility. Its lead product is amezosvatein, a non-mRNA adjuvanted sub-unit vaccine to prevent shingles, a serious medical condition involving a painful, blistering skin rash where 10-18% of people also develop serious, long-lasting nerve pain.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Curevo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsGeorge S., CEO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Curevo's next move

See what Strategic adds

Curevo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.